Patents by Inventor Annette Robichaud

Annette Robichaud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Plethysmograph
    Patent number: 11759120
    Abstract: The present disclosure concerns a plethysmograph. The plethysmograph comprises a housing defining a test cavity configured to enclose a test subject. The plethysmograph further comprises an optical filter providing a spectrally restricted optical access to the test cavity from an exterior of the housing, the optical filter being configured to at least partially transmit light in a transmission band ranging from about 560 nm to about 750 nm; and to at least partially block light in a blocking band ranging from about 380 nm to about 560 nm.
    Type: Grant
    Filed: October 3, 2019
    Date of Patent: September 19, 2023
    Assignee: SCIREQ SCIENTIFIC RESPIRATORY EQUIPMENT INC.
    Inventors: Simon Altmejd, Annette Robichaud, Ilan Benjamin Urovitch, Camilo Guevara Garzon
  • PLETHYSMOGRAPH
    Publication number: 20200107752
    Abstract: The present disclosure concerns a plethysmograph. The plethysmograph comprises a housing defining a test cavity configured to enclose a test subject. The plethysmograph further comprises an optical filter providing a spectrally restricted optical access to the test cavity from an exterior of the housing, the optical filter being configured to at least partially transmit light in a transmission band ranging from about 560 nm to about 750 nm; and to at least partially block light in a blocking band ranging from about 380 nm to about 560 nm.
    Type: Application
    Filed: October 3, 2019
    Publication date: April 9, 2020
    Applicant: SCIREQ - Scientific Respiratory Equipment
    Inventors: Simon Altmejd, Annette Robichaud, ILAN Benjamin Urovitch, Camilo Guevara Garzon
  • Use of phosphodiesterase-4 inhibitors as enhancers of cognition
    Publication number: 20060040981
    Abstract: The present invention is directed to a method of enhancing cognition in a healthy subject comprising administering a safe cognition enhancing amount of a phosphodiesterase-4 inhibitor. In particular, this invention is directed to a method of enhancing memory, learning, retention, recall, awareness and judgement in health subjects comprising administering a safe and effective amount of a phosphodiesterase-4 inhibitor.
    Type: Application
    Filed: November 19, 2003
    Publication date: February 23, 2006
    Inventors: Daniel Dube, Michel Gallant, Patrick Lacombe, Yves Girard, Dwight Macdonald, Richard Friesen, Yves Ducharme, Bernard Cote, Marc Blouin, Evelyn Martins, Daniel Guay, Pierre Hamel, Mario Girard, Richard Frenette, Sebastien Laliberte, Annette Robichaud, Anthony Mastracchio, Helene Perrier
  • Method for treating or preventing emesis
    Patent number: 6610720
    Abstract: Alpha-2 adrenoreceptor agonists are useful for the treatment and/or prevention of emesis in patients.
    Type: Grant
    Filed: August 24, 2001
    Date of Patent: August 26, 2003
    Assignee: Merck Frosst Canada & Co.
    Inventor: Annette Robichaud
  • Method for treating or preventing depression
    Publication number: 20030022814
    Abstract: A neurokinin-1 antagonist or an alpha-2 adrenoreceptor agonist provide an effective therapy in conjunction with a PDE4 inhibitor for the treatment or prevention of depression and/or anxiety. These combinations minimize the side effects of nausea and/or emesis associated with the PDE4 inhibitor and may also provide beneficial antidepressant and/or anti-anxiety effects.
    Type: Application
    Filed: August 23, 2002
    Publication date: January 30, 2003
    Inventors: Scott A Reines, Annette Robichaud, Frederick D Tattersall
  • Method for treating or preventing emesis
    Publication number: 20020045565
    Abstract: Alpha-2 adrenoreceptor agonists are useful for the treatment and/or prevention of emesis in patients.
    Type: Application
    Filed: August 24, 2001
    Publication date: April 18, 2002
    Inventor: Annette Robichaud
  • Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitor
    Publication number: 20020002191
    Abstract: A PDE4 inhibiting compound is represented by 1
    Type: Application
    Filed: May 24, 2001
    Publication date: January 3, 2002
    Inventors: Richard Friesen, Yves Ducharme, Yves Girard, Chun Li, Annette Robichaud
  • Method for treating or preventing depression
    Publication number: 20010049368
    Abstract: A neurokinin-1 antagonist or an alpha-2 adrenoreceptor agonist provide an effective therapy in conjunction with a PDE4 inhibitor for the treatment or prevention of depression and/or anxiety. These combinations minimize the side effects of nausea and/or emesis associated with the PDE4 inhibitor and may also provide beneficial antidepressant and/or anti-anxiety effects.
    Type: Application
    Filed: February 27, 2001
    Publication date: December 6, 2001
    Inventors: Scott A. Reines, Annette Robichaud, Frederick D. Tattersall
  • Assay for emetic activity
    Patent number: 6316434
    Abstract: An assay for emetic activity among inhibitors of type 4 phosphodiesterase (PDE 4) is disclosed. The assay comprises: (A) administering to a test mammal an anesthetic compound in an amount sufficient to cause an anesthetic effect; (B) administering to the test mammal a test compound that has PDE 4 inhibitory activity; (C) observing the test mammal for changes in the anesthetic effect, and (D) correlating any change in the anesthetic effect observed in the anesthetized test mammal to a standard.
    Type: Grant
    Filed: February 24, 2000
    Date of Patent: November 13, 2001
    Assignee: Merck Frosst Canada & Co.
    Inventors: Annette Robichaud, Chantal Savoie, Chi Chung Chang